Trinity Biotech Plc ADR (NASDAQ:TRIB)’s traded shares stood at 0.1 million during the last session, with the company’s beta value hitting 0.76. At the close of trading, the stock’s price was $0.75, to imply an increase of 10.12% or $0.07 in intraday trading. The TRIB share’s 52-week high remains $3.44, putting it -358.67% down since that peak but still an impressive 36.0% since price per share fell to its 52-week low of $0.48. The company has a valuation of $13.94M, with an average of 4.78 million shares in intraday trading volume over the past 10 days and average of 816.79K shares over the past 3 months.
Trinity Biotech Plc ADR (NASDAQ:TRIB) trade information
After registering a 10.12% upside in the last session, Trinity Biotech Plc ADR (TRIB) has traded red over the past five days. The 5-day price performance for the stock is 10.62%, and 18.11% over 30 days. With these gigs, the year-to-date price performance is -65.91%. Short interest in Trinity Biotech Plc ADR (NASDAQ:TRIB) saw shorts transact 45521.0 shares and set a 0.85 days time to cover.
TRIB Dividends
Trinity Biotech Plc ADR has its next earnings report out on 2025-May-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. The company’s average dividend yield trailing the past 5-year period is 1.19%.
Trinity Biotech Plc ADR (NASDAQ:TRIB)’s Major holders
Trinity Biotech Plc ADR insiders hold 12.01% of total outstanding shares, with institutional holders owning 4.62% of the shares at 5.26% float percentage. In total, 4.62% institutions holds shares in the company, led by PERCEPTIVE ADVISORS LLC. As of 2024-06-30, the company held over 1.8 million shares (or 0.9508% of shares), all amounting to roughly $3.83 million.
The next major institution holding the largest number of shares is HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC with 0.33 million shares, or about 0.1763% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.71 million.
Going by data provided on Apr 30, 2025, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 16.64 shares. This is just over 0.74% of the total shares, with a market valuation of $12481.0
